Training for safe handling of dangerous pathogens
BSL-3 Practices Core
This study is creating a training program at the University of Chicago to help researchers safely handle dangerous germs and toxins, making sure they know how to stay safe and respond in emergencies while doing their important work.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Chicago NIH-funded |
| Lab location | 1 site (Chicago, United States) |
| Project ID | NIH-10910208 on NIH RePORTER |
What this research studies
This research focuses on establishing a core program at the University of Chicago to provide comprehensive training in biosafety practices for handling pathogenic microorganisms and toxins. The program includes a curriculum that covers biosecurity, risk assessment, and emergency response plans, ensuring that personnel are well-prepared to work safely in high-containment environments. Training methods include annual group sessions, personalized one-on-one mentoring, and ongoing monthly training to reinforce skills and knowledge. The goal is to enhance the safety and effectiveness of research involving hazardous biological agents.
Who could benefit from this research
Good fit: Ideal candidates for participation include researchers and laboratory personnel who work with pathogenic microorganisms and require training in biosafety practices.
Not a fit: Patients who do not work in laboratory settings or are not involved in research with hazardous biological agents may not receive any benefit from this research.
Why it matters
Potential benefit: If successful, this research could significantly improve the safety protocols for handling dangerous pathogens, thereby reducing the risk of exposure and contamination.
How similar studies have performed: Similar training programs in biosafety have shown success in enhancing safety practices in laboratories, indicating that this approach is effective and beneficial.
Where this research is happening
Chicago, United States
- University of Chicago — Chicago, United States (Active)
Researchers
- Principal investigator: Kanabrocki, Joseph a. — University of Chicago
- Study coordinator: Kanabrocki, Joseph a.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.